- Home
- QGEN vs IVZ Comparison
QGEN vs IVZ Comparison
Compare QGEN & IVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- IVZ
- Stock Information
- Founded
- QGEN 1986
- IVZ 1935
- Country
- QGEN Netherlands
- IVZ United States
- Employees
- QGEN N/A
- IVZ N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- IVZ Investment Managers
- Sector
- QGEN Health Care
- IVZ Finance
- Exchange
- QGEN Nasdaq
- IVZ Nasdaq
- Market Cap
- QGEN 10.3B
- IVZ 9.9B
- IPO Year
- QGEN 1996
- IVZ 1995
- Fundamental
- Price
- QGEN $45.80
- IVZ $22.61
- Analyst Decision
- QGEN Buy
- IVZ Hold
- Analyst Count
- QGEN 8
- IVZ 16
- Target Price
- QGEN $51.01
- IVZ $19.36
- AVG Volume (30 Days)
- QGEN 1.3M
- IVZ 3.5M
- Earning Date
- QGEN 11-05-2025
- IVZ 10-21-2025
- Dividend Yield
- QGEN 3.32%
- IVZ 3.79%
- EPS Growth
- QGEN 405.09
- IVZ N/A
- EPS
- QGEN 1.69
- IVZ 0.93
- Revenue
- QGEN $2,040,067,000.00
- IVZ $6,153,100,000.00
- Revenue This Year
- QGEN $7.22
- IVZ N/A
- Revenue Next Year
- QGEN $5.66
- IVZ $9.86
- P/E Ratio
- QGEN $26.93
- IVZ $23.85
- Revenue Growth
- QGEN 5.15
- IVZ 5.83
- 52 Week Low
- QGEN $37.63
- IVZ $11.60
- 52 Week High
- QGEN $51.88
- IVZ $22.78
- Technical
- Relative Strength Index (RSI)
- QGEN 39.15
- IVZ 66.80
- Support Level
- QGEN $45.18
- IVZ $21.89
- Resistance Level
- QGEN $46.18
- IVZ $22.73
- Average True Range (ATR)
- QGEN 0.67
- IVZ 0.46
- MACD
- QGEN -0.13
- IVZ -0.05
- Stochastic Oscillator
- QGEN 24.04
- IVZ 89.71
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About IVZ Invesco Ltd
Invesco provides investment-management services to retail (68% of managed assets) and institutional (32%) clients. At the end of July 2025, the firm had $2.025 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 46% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 30% of its AUM sourced from Europe, Africa, and the Middle East (15%) and Asia (15%).